|
|
|
Volumn 85, Issue 12, 1996, Pages 895-898
|
|
Lipid optimization in the secondary and primary prevention - Are there still doubts after 4S, WOS and CARE?;Lipidoptimierung in der Sekundar- und Primarpravention - Gibt es nach 4S, WOS und CARE noch Zweifel?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
BEZAFIBRATE;
COLESTIPOL;
COLESTYRAMINE;
MEVINOLIN;
NICOTINIC ACID;
PRAVASTATIN;
SIMVASTATIN;
ANGIOGRAPHY;
ATHEROSCLEROSIS;
EDITORIAL;
HEART INFARCTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
LIPID BLOOD LEVEL;
MORBIDITY;
MORTALITY;
RISK FACTOR;
ANGIOCARDIOGRAPHY;
BLOOD;
CAUSE OF DEATH;
CORONARY ARTERY ATHEROSCLEROSIS;
CORONARY ARTERY DISEASE;
HYPERLIPIDEMIA;
SURVIVAL RATE;
CAUSE OF DEATH;
CORONARY ANGIOGRAPHY;
CORONARY ARTERIOSCLEROSIS;
CORONARY DISEASE;
HUMANS;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIAS;
RISK FACTORS;
SURVIVAL RATE;
|
|
EID: 0030476803
PISSN: 03005860
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
